| Original language | English |
|---|---|
| Pages (from-to) | 345 - 351 |
| Number of pages | 7 |
| Journal | Journal of Pharmacology and Experimental Therapeutics |
| Volume | 313 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 2005 |
Cite this
}
Lymphatic absorption is the primary contributor to the systemic availability of epoetin alfa following subcutaneous administration to sheep. / McLennan, Danielle N; Porter, Christopher John H; Edwards, Glenn A; Martin, Steven W; Heatherington, Anne C; Charman, Susan A.
In: Journal of Pharmacology and Experimental Therapeutics, Vol. 313, No. 1, 2005, p. 345 - 351.Research output: Contribution to journal › Article › Research › peer-review
TY - JOUR
T1 - Lymphatic absorption is the primary contributor to the systemic availability of epoetin alfa following subcutaneous administration to sheep
AU - McLennan, Danielle N
AU - Porter, Christopher John H
AU - Edwards, Glenn A
AU - Martin, Steven W
AU - Heatherington, Anne C
AU - Charman, Susan A
PY - 2005
Y1 - 2005
U2 - 10.1124/jpet.104.078790
DO - 10.1124/jpet.104.078790
M3 - Article
VL - 313
SP - 345
EP - 351
JO - Journal of Pharmacology and Experimental Therapeutics
JF - Journal of Pharmacology and Experimental Therapeutics
SN - 0022-3565
IS - 1
ER -